Janssen Products LP
13 drugs in NADAC|0 Generic,13 Brand
Janssen Products LP lists 13 NDCs in the CMS NADAC file (0 generic, 13 brand), at an average NADAC of $190.43 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
13
0G / 13B
Avg Price / Unit
$190.4320
$10.92 – $1038.70
Avg 7d Change
-0.01%
Across 8 drugs with changes
7d Activity
of 13 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Erythropoietin market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Erythropoiesis-stimulating Agent therapeutic class
Review the broader class where Janssen Products LP has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Janssen Products LP make?
Janssen Products LP lists 13 NDCs in the CMS NADAC file — 0 generic and 13 brand products.
What is the average price of Janssen Products LP drugs?
The average NADAC across Janssen Products LP's portfolio is $190.4320 per unit, ranging from $10.9213 to $1038.6989.
What types of drugs does Janssen Products LP make?
Janssen Products LP makes drugs across 6 FDA pharmacologic classes. The most common by NDC count are Erythropoiesis-stimulating Agent (6), Protease Inhibitor (4), Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor (3), Cytochrome P450 3A Inhibitor (2), Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor (2).
Has Janssen Products LP had any drug recalls?
No FDA enforcement recalls are matched to Janssen Products LP in the openFDA feed.
How has Janssen Products LP's pricing changed recently?
Over the past 7 days, 2 Janssen Products LP products rose and 6 fell, with a portfolio-wide average change of -0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PROCRIT 40,000 UNITS/ML VIAL Erythropoietin | $1038.6989 per ML | +0.24% |
PROCRIT 20,000 UNITS/ML VIAL Erythropoietin | $521.4717 per ML | -0.01% |
PROCRIT 10,000 UNIT/ML VIAL Erythropoietin | $259.8609 per ML | -0.03% |
SYMTUZA 800-150-200-10 MG TAB Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | $152.8673 per EA | -0.06% |
PROCRIT 4,000 UNIT/ML VIAL Erythropoietin | $104.2817 per ML | — |
PREZCOBIX 800 MG-150 MG TABLET DARUNAVIR ETHANOLATE and COBICISTAT | $79.9938 per EA | +0.03% |
PROCRIT 3,000 UNITS/ML VIAL Erythropoietin | $78.0553 per ML | — |
PREZISTA 800 MG TABLET darunavir | $70.1073 per EA | -0.04% |
PROCRIT 2,000 UNITS/ML VIAL Erythropoietin | $52.1233 per ML | — |
EDURANT 25 MG TABLET rilpivirine hydrochloride | $48.0410 per EA | -0.04% |
PREZISTA 600 MG TABLET darunavir | $34.8901 per EA | -0.18% |
INTELENCE 200 MG TABLET etravirine | $24.3032 per EA | — |
INTELENCE 100 MG TABLET etravirine | $10.9213 per EA | — |